Biochemical risk indices, including plasma homocysteine, that prospectively predict mortality in older British people: The National Diet and Nutrition Survey of People Aged 65 Years and over

British Journal of Nutrition

Volumn 104, Issue 6, 2010, Pages 893-899

  Bates, Christopher J ^a   Mansoor, Mohammed A ^b   Pentieva, Kristina D ^c   Hamer, Mark ^d   Mishra, Gita D ^d  

^a MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^b UNIVERSITY OF AGDER   (Norway)

^c UNIVERSITY OF ULSTER   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

B vitamins and inflammatory indices; British National Survey of older adults; Intakes and biochemical indices; Mortality prediction; Plasma homocysteine

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; CREATININE; CYANOCOBALAMIN; FIBRINOGEN; FOLIC ACID; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE; PYRIDOXIC ACID; RIBOFLAVIN; CHOLESTEROL; CHYMOTRYPSIN; VITAMIN B COMPLEX;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; FEMALE; FIBRINOGEN BLOOD LEVEL; GERIATRIC NUTRITION; HUMAN; MALE; MORTALITY; NUTRITIONAL VALUE; PREDICTION; PROTEIN INTAKE; RISK ASSESSMENT; RISK FACTOR; UNITED KINGDOM; VASCULAR DISEASE; BLOOD; DIET; DRUG ANTAGONISM; EVALUATION; METABOLISM; NUTRITIONAL STATUS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHOLESTEROL; CHYMOTRYPSIN; CREATININE; DIET SURVEYS; DIETARY PROTEINS; ENERGY INTAKE; FEMALE; FIBRINOGEN; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HOMOCYSTEINE; HUMANS; MALE; MORTALITY; NUTRITIONAL STATUS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; VASCULAR DISEASES; VITAMIN B COMPLEX;

EID: 77957261187     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114510001236     Document Type: Article

References (41)

1. Finch S, Doyle W, Lowe C, et al. (1998) National Diet and Nutrition Survey: People Aged 65 Years or Over. vol. 1: Report of the Diet and Nutrition Survey. London: The Stationery Office.
2. Kannel WB (2002) Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 11, 101-107.
3. de Ruijter W, Westendorp RGJ, Assendelft WJJ, et al. (2009) Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: Population based observational cohort study. BMJ 338, a3083.
4. Perry I, Refsum H, Morris R, et al. (1996) Serum total homocysteine and coronary heart disease in middle-aged British men. Heart 75, Suppl. 1, 53 (abstr).
5. Verhoef P, Stampfer MJ, Buring JE, et al. (1996) Homocysteine metabolism and risk of myocardial infarction: Relation with vitamins B6, B12, and folate. Am J Epidemiol 143, 845-859.
6. Nygard O, Nordrehaug JE, Refsum H, et al. (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337, 230-236. (Pubitemid 27310438)
7. Homocysteine-Lowering Triallists' Collaboration (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 316, 894-898.
8. Bostom AG, Silbershatz H, Rosenberg IH, et al. (1999) Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159, 1077-1080. (Pubitemid 29230859)
9. Kark JD, Selhub J, Adler B, et al. (1999) Nonfasting plasma total homocysteine level and mortality in middle-aged and elderly men and women in Jerusalem. Ann Intern Med 131, 321-330. (Pubitemid 29424625)
10. Whincup P, Refsum H, Perry I, et al. (1999) Serum total homocysteine and coronary heart disease: Prospective study in middle aged men. Heart 82, 448-454.
11. Anderson JL, Muhlestein JB, Horne BD, et al. (2000) Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation 102, 1227-1232.
12. Omland T, Samuelsson A, Hartford M, et al. (2000) Serum homocysteine as an indicator of survival in patients with acute coronary syndromes. Arch Intern Med 160, 1834-1840.
13. Zhao X-Q, Kosinski A, Malinow MR, et al. (2000) Association of total plasma homocyst(e)ine levels and 8-years mortality following PTCA or CABG in EAST. Circulation 102 (abstr 3380).
14. Vollset SE, Refsum H, Tverdal A, et al. (2001) Plasma total homocysteine and cardiovascular and noncardiovascular mortality: The Hordaland Homocysteine Study. Am J Clin Nutr 74, 130-136. (Pubitemid 32574920)
15. Blacher J, Benetos A, Kirzin JM, et al. (2002) Relation of plasma total homocysteine to cardiovascular mortality in a French population. Am J Cardiol 90, 591-595.
16. Zylberstein DE, Bengtsson C, Bjorkelund C, et al. (2004) Serum homocysteine in relation to morbidity and mortality from coronary heart disease: A 24-year follow-up of the population study of women in Gothenburg. Circulation 109, 601-606.
17. Virtanen JK, Voutilainen S, Alfthan G, et al. (2005) Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors. J Intern Med 257, 255-262.
18. Menon V, Sarnak MJ, Greene T, et al. (2006) Relationship between homocysteine and mortality in chronic kidney disease. Circulation 113, 1572-1577. (Pubitemid 43739416)
19. Refsum H, Nurk E, Smith AD, et al. (2006) The Hordaland Homocysteine Study: A community-based study of homocysteine, its determinants, and associations with disease. Am J Clin Nutr 136, 1731S-1740S.
20. Rossi GP, Maiolino G, Seccia TM, et al. (2006) Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. J Hypertens 24, 851-859.
21. Selhub J (2006) The many facets of hyperhomocysteinemia: Studies from the Framingham cohorts. J. Nutr 136, 1726S-1730S.
22. Gonzalez S, Huerta JM, Fernandez S, et al. (2007) Homocysteine increases the risk of mortality in elderly individuals. Br J. Nutr 97, 1138-1143.
23. Dangour AD, Breeze E, Clarke R, et al. (2008) Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom. J. Nutr 138, 1121-1128.
24. Mansoor M, Svardal A & Ueland P (1992) Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine and glutathione in human plasma. Anal Biochem 200, 218-229.
25. Bates CJ, Pentieva KD, Matthews N, et al. (1999) A simple, sensitive and reproducible assay for pyridoxal phosphate in human plasma. Clin Chim Acta 280, 101-111.
26. Stolzenberg-Solomon RZ, Miller ER, Maguire MG, et al. (1999) Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population. Am J Clin Nutr 69, 467-475.
27. Danesh J, Wheeler JG, Hirschfield GM, et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350, 1387-1397.
28. Bates CJ, Mansoor MA, Gregory J, et al. (2002) Correlates of plasma homocysteine, cysteine and cysteinyl-glycine in respondents in the British National Diet and Nutrition Survey of young people aged 4-18 years, and a comparison with the survey of people aged 65 years and over. Br J. Nutr 87, 71-79.
29. Haim M, Tanne D, Goldbourt U, et al. (2006) Serum homocysteine and long-term risk of myocardial infarction and sudden death in patients with coronary heart disease. Cardiology 107, 52-56.
30. Jia X, Aucott LS & McNeill G (2007) Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J. Nutr 98, 593-599.
31. Bates CJ, Mansoor MA, van der Pols JC, et al. (1998) Plasma total homocysteine in 972 British men and women aged 65 years and over. Eur J Clin Nutr 51, 691-697.
32. Bates CJ, Pentieva KD & Prentice A (1999) An appraisal of vitamin B6 status indices and associated confounders, in young people aged 4-18 years and in people aged 65 years and over, in two national British surveys. Public Health Nutr 2, 529-535.
33. Bates CJ, Pentieva KD, Prentice A, et al. (1999) Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. Br J. Nutr 81, 191-201.
34. Homocysteine Studies Collaboration (2002) Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis. JAMA 288, 2015-2022.
35. Wald DS, Law M & Morris JK (2002) Homocysteine and cardiovascular disease: Evidence on causality from a metaanalysis. BMJ 325, 1202-1206.
36. Cesari M, Onder G, Zamboni V, et al. (2009) C-reactive protein and lipid parameters in older persons aged 80 years and older. J. Nutr Health Aging 13, 587-593.
37. Zethelius B, Berglund L, Sundström J, et al. (2008) Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 358, 2107-2116.
38. Bates CJ, Lean MEJ, Mansoor MA, et al. (2004) Nutrient intakes: biochemical and risk indices associated with type 2 diabetes and glycosylated haemoglobin, in the British National Diet and Nutrition Survey of people aged 65 years and over. Diabet Med 21, 677-684.
39. Chonchol M, Katz R, Fried LF, et al. (2010) Glycosylated hemoglobin and the risk of death and cardiovascular mortality in the elderly. Nutr Metab Cardiovasc Dis 20, 15-21.
40. Hamer M, Bates CJ & Mishra GD (2010) Depressive symptoms, physical function, and risk of mortality: National Diet and Nutrition Survey in older adults 65+ years. Am J Geriatr Psychiat (In the Press).
41. Virtanen JK, Voutilainen S, Rissanen TH, et al. (2005) High dietary methionine intake increases the risk of acute coronary events in middle-aged men. Nutr Metab Cardiovasc Dis 16, 113-120.